Compare EQBK & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQBK | QDEL |
|---|---|---|
| Founded | 2002 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 993.2M | 1.2B |
| IPO Year | 2015 | 2022 |
| Metric | EQBK | QDEL |
|---|---|---|
| Price | $50.64 | $16.69 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $51.33 | $28.25 |
| AVG Volume (30 Days) | 135.8K | ★ 1.1M |
| Earning Date | 04-14-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.80 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $74.58 | $3.51 |
| Revenue Next Year | $5.11 | $3.86 |
| P/E Ratio | $63.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.04 | $9.92 |
| 52 Week High | $51.73 | $35.58 |
| Indicator | EQBK | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 63.39 | 51.93 |
| Support Level | $43.99 | $15.52 |
| Resistance Level | $51.61 | $17.78 |
| Average True Range (ATR) | 1.31 | 1.01 |
| MACD | 0.05 | -0.25 |
| Stochastic Oscillator | 86.19 | 30.27 |
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.